Bone Biologics Corporation
BBLG
$2.16
-$0.04-1.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 141.77% | -17.40% | -6.77% | 52.93% | -27.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.00% | -25.77% | 144.68% | -46.14% | -25.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -19.02% | -33.08% | -40.69% | 97.78% |
| Total Current Assets | 121.44% | -18.11% | -5.03% | 27.31% | -16.83% |
|
|
|||||
| Total Current Assets | 121.44% | -18.11% | -5.03% | 27.31% | -16.83% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 121.44% | -18.11% | -5.03% | 27.31% | -16.83% |
|
|
|||||
| Total Accounts Payable | 62.91% | -33.57% | 96.21% | -18.03% | 58.62% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -27.27% | -29.79% | -94.36% | 58.37% | 185.87% |
| Total Other Current Liabilities | -27.27% | -29.79% | -94.36% | 58.37% | 185.87% |
| Total Current Liabilities | 61.66% | -33.49% | 38.15% | -3.90% | 72.84% |
|
|
|||||
| Total Current Liabilities | 61.66% | -33.49% | 38.15% | -3.90% | 72.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.66% | -33.49% | 38.15% | -3.90% | 72.84% |
|
|
|||||
| Common Stock & APIC | 4.98% | 0.50% | 1.39% | 2.13% | 0.02% |
| Retained Earnings | -0.86% | -1.20% | -1.82% | -1.14% | -0.96% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 126.60% | -16.44% | -8.14% | 30.37% | -20.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.60% | -16.44% | -8.14% | 30.37% | -20.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.60% | -16.44% | -8.14% | 30.37% | -20.84% |
|
|
|||||